Cost-effectiveness of oral pre-exposure prophylaxis and expanded antiretroviral therapy for preventing HIV infections in the presence of drug resistance among men who have sex with men in China: A mathematical modelling study.

Jin, Xinye; Shi, Lingen; Wang, Congyue; Qiu, Tao; Yin, Yi; Shen, Mingwang; Fu, Gengfeng; Peng, Zhihang

Jin, Xinye; Shi, Lingen; Wang, Congyue; Qiu, Tao; Yin, Yi; Shen, Mingwang; Fu, Gengfeng; Peng, Zhihang.

Afiliación

Jin X; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211100, China.
Shi L; Jiangsu Provincial Center for Disease Control and Prevention, Institute for STI and HIV Control and Prevention, Nanjing, Jiangsu 210009, China.
Wang C; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211100, China.
Qiu T; Jiangsu Provincial Center for Disease Control and Prevention, Institute for STI and HIV Control and Prevention, Nanjing, Jiangsu 210009, China.
Yin Y; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211100, China.
Shen M; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China.
Fu G; Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi'an, Shaanxi 710061, China.
Peng Z; Jiangsu Provincial Center for Disease Control and Prevention, Institute for STI and HIV Control and Prevention, Nanjing, Jiangsu 210009, China.

Lancet Reg Health West Pac ; 23: 100462, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35542892

Palabras clave

ADR, acquired drug resistance; ART, antiretroviral therapy; Chinese MSM; Cost-effectiveness; GDP, gross domestic product; HIV drug-resistance; HIVDR, HIV drug resistance; ICER, incremental cost-effectiveness ratio; MSM, men who have sex with men; Mathematical model; NLS, nonlinear least-squares; PrEP, pre-exposure prophylaxis; Pre-exposure prophylaxis; QALYs, quality-adjusted life years; TDF/FTC, tenofovir disoproxil fumarate/emtricitabine; TDR, transmitted drug resistance

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Lancet Reg Health West Pac Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google